ClearPoint Neuro, Inc. — Director's Dealing 2026

Feb 26, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2026-02-25

Reporting Person: BURNETT JOSEPH (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-25	Common Stock	S	19951	$15.17	Disposed	193231	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12499	Direct

Footnotes

F1: The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.

F2: Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.15 to $15.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Reflects 934 shares previously owned by the Joseph M. Burnett Trust dated 10/20/2022 (the "Trust") which were transferred to the Reporting Person as direct ownership on February 6, 2026.

F4: These shares are owned directly by the Trust and indirectly by Joseph M. Burnett as trustee of the trust.